Actively Recruiting

Age: 18Years - 75Years
FEMALE
Healthy Volunteers
ID07500428

Construction of a Standardized Benchmark Evaluation System for Intelligent Breast Ultrasound Image Interpretation and Systematic Performance Assessment of Multimodal Artificial Intelligence Models Based on ACR BI-RADS v2025 Criteria

Led by Peking Union Medical College Hospital · Updated on 2026-03-30

1380

Participants Needed

1

Research Sites

12 weeks

Total Duration

On this page

Sponsors

P

Peking Union Medical College Hospital

Lead Sponsor

C

Chinese Academy of Medical Sciences

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are conducting a single-center, retrospective observational study to develop a standardized benchmark system for evaluating intelligent breast ultrasound image interpretation. The study focuses on assessing the diagnostic accuracy of current mainstream multimodal artificial intelligence (AI) models in classifying breast ultrasound images according to the American College of Radiology (ACR) BI-RADS v2025 criteria. This research aims to address variability in ultrasound interpretation, especially for certain lesion categories, and to systematically evaluate AI performance using expert-annotated images. The study uses approximately 1,380 de-identified B-mode breast ultrasound images collected from an institutional archive and open-access datasets, covering normal breast tissue, benign lesions, and malignant lesions. Expert radiologists with varying experience levels will annotate all images independently. Baseline deep learning models (ResNet-50 and USFM) will establish performance baselines, and multiple multimodal large language models (MLLMs) will be evaluated using standardized chain-of-thought prompts through API calls. Safety assessments include out-of-distribution rejection testing and temperature-stability experiments. Participants are not directly involved as the study retrospectively analyzes existing images. Researchers will evaluate diagnostic accuracy, BI-RADS classification accuracy, agreement with expert consensus, and other performance metrics at study completion, approximately 12 months after starting. The study also monitors model robustness and safety through specific tests. The total study duration extends from March 2026 to March 2027.

CONDITIONS

Brief Title

Construction of a Benchmark for Breast Ultrasound AI Interpretation and Performance Evaluation of Multimodal AI Models

Who Can Participate

Age: 18Years - 75Years
FEMALE
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Breast ultrasound B-mode grayscale images from institutional databases or approved open-access datasets
  • Images must have adequate quality for clinical diagnosis with clear visualization
  • Pathological diagnosis confirmed for benign and malignant lesions, or normal breast status confirmed by an experienced senior radiologist
  • Images fully de-identified with no personal identification information
Not Eligible

You will not qualify if you...

  • Severely degraded image quality preventing meaningful BI-RADS assessment
  • Duplicate images from the same patient (only the most representative retained)
  • Images containing residual personal identification information after de-identification
  • Cases with unclear, disputed, or missing pathological diagnosis
  • Non-B-mode ultrasound images such as elastography, contrast-enhanced ultrasound, and Doppler imaging

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

No participant visits; eligibility is based on image dataset criteria.

Diagnostic Evaluation

Duration - Up to 12 months

Participants' breast ultrasound images are retrospectively evaluated by multiple AI systems and expert radiologists to assess diagnostic accuracy and BI-RADS classification.

No participant visits; evaluation is performed on de-identified images.

Long-term Monitoring

Duration - Up to 12 months

Ongoing analysis of AI model performance including out-of-distribution rejection tests and stability assessments.

No participant visits; monitoring conducted through data analysis.

Trial Site Locations

Total: 1 location

1

Peking Union Medical College Hospital

Beijing, China, 100730

Actively Recruiting

Loading map...

Research Team

Q

Qingli Zhu, MD

Y

Yinglan Wu, MD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

3

Similar Trials

A Phase 2 Trial of (Z)-Endoxifen and Goserelin as Neoadjuvan...

Breast Neoplasms

Actively Recruiting

15 locations

18F-FDG Versus 68Ga-FAPI-46 as PET Tracer in ER-positive Bre...

Breast Cancer

Actively Recruiting

1 location

Prospective, Single-arm, Single-center Clinical Study of Dar...

Breast Neoplasms

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Performance of ChatGPT on a Radiology Board-style Examination: Insights into Current Strengths and Limitations.

Rajesh Bhayana, Satheesh Krishna, Robert R Bleakney

https://pubmed.ncbi.nlm.nih.gov/37191485

Underdiagnosis bias of artificial intelligence algorithms applied to chest radiographs in under-served patient populations.

Laleh Seyyed-Kalantari, Haoran Zhang, Matthew B A McDermott...

https://pubmed.ncbi.nlm.nih.gov/34893776

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.

Hyuna Sung, Jacques Ferlay, Rebecca L Siegel...

https://pubmed.ncbi.nlm.nih.gov/33538338

Using a Large Language Model for Breast Imaging Reporting and Data System Classification and Malignancy Prediction to Enhance Breast Ultrasound Diagnosis: Retrospective Study.

Su Miaojiao, Liang Xia, Zeng Xian Tao...

https://pubmed.ncbi.nlm.nih.gov/40498674